151 related articles for article (PubMed ID: 17536214)
1. Administration of anti-IgE to a Churg-Strauss syndrome patient.
Giavina-Bianchi P; Giavina-Bianchi M; Agondi R; Kalil J
Int Arch Allergy Immunol; 2007; 144(2):155-8. PubMed ID: 17536214
[TBL] [Abstract][Full Text] [Related]
2. Churg-Strauss vasculitis in a patient treated with omalizumab.
Bargagli E; Madioni C; Olivieri C; Penza F; Rottoli P
J Asthma; 2008 Mar; 45(2):115-6. PubMed ID: 18350402
[TBL] [Abstract][Full Text] [Related]
3. Churg-strauss syndrome in patients treated with omalizumab.
Wechsler ME; Wong DA; Miller MK; Lawrence-Miyasaki L
Chest; 2009 Aug; 136(2):507-518. PubMed ID: 19411292
[TBL] [Abstract][Full Text] [Related]
4. Persistent airflow obstruction in asthma of patients with Churg-Strauss syndrome and long-term follow-up.
Cottin V; Khouatra C; Dubost R; Glérant JC; Cordier JF
Allergy; 2009 Apr; 64(4):589-95. PubMed ID: 19154547
[TBL] [Abstract][Full Text] [Related]
5. Three months' administration of anti-IgE to a patient with Churg-Strauss syndrome.
Giavina-Bianchi P; Giavina-Bianchi M; Agondi R; Kalil J
J Allergy Clin Immunol; 2007 May; 119(5):1279; author reply 1279-80. PubMed ID: 17349685
[No Abstract] [Full Text] [Related]
6. Successful management of Churg-Strauss syndrome using omalizumab as adjuvant immunomodulatory therapy: first documented pediatric case.
Iglesias E; Camacho Lovillo M; Delgado Pecellín I; Lirola Cruz MJ; Falcón Neyra MD; Salazar Quero JC; Bernabeu-Wittel J; González Valencia JP; Neth O
Pediatr Pulmonol; 2014 Mar; 49(3):E78-81. PubMed ID: 24136903
[TBL] [Abstract][Full Text] [Related]
7. Difficult asthma and Churg-Strauss-like syndrome: a cautionary tale.
Lau EM; Cooper W; Bye PT; Yan K
Respirology; 2011 Jan; 16(1):180-1. PubMed ID: 21504509
[No Abstract] [Full Text] [Related]
8. The economic value of anti-IgE in severe persistent, IgE-mediated (allergic) asthma patients: adaptation of INNOVATE to Sweden.
Dewilde S; Turk F; Tambour M; Sandström T
Curr Med Res Opin; 2006 Sep; 22(9):1765-76. PubMed ID: 16968580
[TBL] [Abstract][Full Text] [Related]
9. RANTES in exhaled breath condensate of patients with severe persistent allergic asthma during omalizumab therapy.
Zietkowski Z; Skiepko R; Tomasiak-Lozowska MM; Lenczewska D; Bodzenta-Lukaszyk A
Int Arch Allergy Immunol; 2011; 154(1):25-32. PubMed ID: 20664274
[TBL] [Abstract][Full Text] [Related]
10. [Churg-Strauss syndrome: clinical features and long-term follow-up of 16 patients].
Lou J; Xu WB
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(8):524-8. PubMed ID: 19567070
[TBL] [Abstract][Full Text] [Related]
11. Churg-Strauss syndrome: survival for 26 years.
Vemuri P; Greenberger PA; Patterson R
Ann Allergy Asthma Immunol; 2002 Jun; 88(6):640-3. PubMed ID: 12086374
[TBL] [Abstract][Full Text] [Related]
12. [Clinical features of allergic granulomatosis and angiitis (Churg-Strauss syndrome). Association with asthma symptoms].
Higashimoto I; Umehara F; Koreeda Y; Watanabe T; Kawabata M; Arimura K; Osame M
Arerugi; 1996 Nov; 45(11):1154-60. PubMed ID: 8990526
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma.
Holgate ST; Chuchalin AG; Hébert J; Lötvall J; Persson GB; Chung KF; Bousquet J; Kerstjens HA; Fox H; Thirlwell J; Cioppa GD;
Clin Exp Allergy; 2004 Apr; 34(4):632-8. PubMed ID: 15080818
[TBL] [Abstract][Full Text] [Related]
14. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
Holgate ST; Djukanović R; Casale T; Bousquet J
Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of long-term safety of the anti-IgE antibody, omalizumab, in children with allergic asthma.
Berger W; Gupta N; McAlary M; Fowler-Taylor A
Ann Allergy Asthma Immunol; 2003 Aug; 91(2):182-8. PubMed ID: 12952113
[TBL] [Abstract][Full Text] [Related]
16. Clinical manifestations and treatment of Churg-Strauss syndrome.
Baldini C; Talarico R; Della Rossa A; Bombardieri S
Rheum Dis Clin North Am; 2010 Aug; 36(3):527-43. PubMed ID: 20688248
[TBL] [Abstract][Full Text] [Related]
17. Changes of immunomodulatory cytokines associated with omalizumab therapy for severe persistent asthma.
Shimizu Y; Dobashi K; Fueki N; Fueki M; Okada T; Tomioka S; Makino S; Mori M
J Biol Regul Homeost Agents; 2011; 25(2):177-86. PubMed ID: 21880206
[TBL] [Abstract][Full Text] [Related]
18. [Pneumology. Anti-IgE antibodies in the treatment of asthma].
Leuenberger P; Sauty A; Rochat T
Rev Med Suisse; 2007 Jan; 3(93):56-9. PubMed ID: 17354662
[TBL] [Abstract][Full Text] [Related]
19. Omalizumab in the treatment of asthma.
Tan R; Corren J
Expert Rev Respir Med; 2011 Dec; 5(6):747-56. PubMed ID: 22082161
[TBL] [Abstract][Full Text] [Related]
20. [Anti-IgE therapy in persistent allergic asthma].
Skiepko R; Zietkowski Z; Tomasiak-Łozowska MM; Bodzenta-Łukaszyk A
Przegl Lek; 2009; 66(3):141-4. PubMed ID: 19689039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
